Sulzer Medica gets 60-day stay on single claims injunction
This article was originally published in Clinica
Executive Summary
Sulzer Medica's injunction on single claims from patients implanted with faulty Inter-Op hip shells and tibial baseplates will stay in place for 60 days, the US federal court of appeals said last week. In a late sitting on November 29, the court agreed to keep the injunction until February 1 2002, while an independent mediator reviews the company's proposed class action settlement.